1. Home
  2. CDTX vs HIO Comparison

CDTX vs HIO Comparison

Compare CDTX & HIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • HIO
  • Stock Information
  • Founded
  • CDTX 2012
  • HIO 1993
  • Country
  • CDTX United States
  • HIO United States
  • Employees
  • CDTX N/A
  • HIO N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • HIO Finance/Investors Services
  • Sector
  • CDTX Health Care
  • HIO Finance
  • Exchange
  • CDTX Nasdaq
  • HIO Nasdaq
  • Market Cap
  • CDTX 333.3M
  • HIO 369.0M
  • IPO Year
  • CDTX 2015
  • HIO N/A
  • Fundamental
  • Price
  • CDTX $21.02
  • HIO $3.93
  • Analyst Decision
  • CDTX Strong Buy
  • HIO
  • Analyst Count
  • CDTX 9
  • HIO 0
  • Target Price
  • CDTX $41.29
  • HIO N/A
  • AVG Volume (30 Days)
  • CDTX 202.2K
  • HIO 305.3K
  • Earning Date
  • CDTX 08-12-2025
  • HIO 01-01-0001
  • Dividend Yield
  • CDTX N/A
  • HIO 10.33%
  • EPS Growth
  • CDTX N/A
  • HIO N/A
  • EPS
  • CDTX N/A
  • HIO N/A
  • Revenue
  • CDTX $302,000.00
  • HIO N/A
  • Revenue This Year
  • CDTX N/A
  • HIO N/A
  • Revenue Next Year
  • CDTX N/A
  • HIO N/A
  • P/E Ratio
  • CDTX N/A
  • HIO N/A
  • Revenue Growth
  • CDTX N/A
  • HIO N/A
  • 52 Week Low
  • CDTX $10.14
  • HIO $3.52
  • 52 Week High
  • CDTX $28.42
  • HIO $4.03
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 39.72
  • HIO 61.98
  • Support Level
  • CDTX $21.14
  • HIO $3.79
  • Resistance Level
  • CDTX $22.60
  • HIO $3.92
  • Average True Range (ATR)
  • CDTX 1.54
  • HIO 0.03
  • MACD
  • CDTX -0.51
  • HIO 0.00
  • Stochastic Oscillator
  • CDTX 12.57
  • HIO 92.86

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About HIO Western Asset High Income Opportunity Fund Inc.

Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.

Share on Social Networks: